The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.

NCT04562831 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

380

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DIETARY_SUPPLEMENT: EH301 (Nicotinamide Riboside/Pterostilbene)

Sponsor

Haukeland University Hospital

Collaborators

[object Object]